Question to the Ministry of Defence:
To ask the Secretary of State for Defence, what stocks of Lariam his Department currently holds.
The latest assessment of anti-malarial drugs held by the Ministry of Defence was undertaken in August 2015. This showed that mefloquine (commercially known as Lariam) represented 1.2% of all anti-malarial tablets held and, in terms of doses for a sixth month deployment, 14% of the stock.